Watson's nabumetone tablets get FDA OK

PARSIPPANY, N.J. — The Food and Drug Administration has approved a drug for arthritis made by Watson Pharmaceuticals, Watson said Friday.

The drug maker announced the approval of nabumetone tablets in the 500-mg and 750-mg strength. The drug is used to treat signs and symptoms of rheumatoid arthritis and osteoarthritis.

Nabumetone had sales of $58 million during the 12-month period ended in April, according to IMS Health.

Login or Register to post a comment.